News

Tuesday, 12. June 2018 | Filed under Company News

Company News: Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018

Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company is going to attend several industry conferences in the third quarter of 2018.

Read more…

Thursday, 7. June 2018 | Filed under Company News

Company News: Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.

— Multiple scientific conference contributions at ASM Microbe highlight benefits of Unyvero LRT

— First commercial evaluation agreements expected in the coming weeks

Curetis N.V. (the “Company” and together with its subsidiaries “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the U.S. commercial launch of its Unyvero sample-to-answer molecular diagnostic system and the Unyvero LRT Application Cartridge for lower respiratory tract infections at the ASM Microbe 2018 Congress in Atlanta, GA, USA (June 7-11). Curetis obtained regulatory clearance for the Unyvero System and Unyvero LRT from the U.S. FDA in April this year.

Read more…

Tuesday, 29. May 2018 | Filed under Company News

Company News: BioNTech Appoints Dr. Özlem Türeci as Chief Medical Officer

BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced the appointment of Özlem Türeci,  M.D., as Chief Medical Officer, effective June 1, 2018. Dr. Türeci has chaired BioNTech´s Scientific and Clinical Advisory Board since the inception of the Company.

Read more…